Your Article Summary
Mass screening for prostate cancer in patients with end-stage renal disease: a comparative study
BJU International, 09/11/06
Wada, Yoshihiro, et al. - Conclusion: The serum PSA level was slightly higher and the incidence of prostate cancer at higher PSA levels appeared to be greater in men with ESRD than in healthy controls. The findings of this large study suggest that PSA screening is useful for the diagnosis of prostate cancer in these patients
Related Articles
Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer
Pituitary, 10/29/09
Relevance Score: 93%
Screening for Cancer
MedLinePlus, 11/02/09
Relevance Score: 91%
Rethinking Screening for Breast Cancer and Prostate Cancer
JAMA, 10/23/09
Relevance Score: 91%
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Relevance Score: 91%
Prostate specific antigen for early detection of prostate cancer: longitudinal study
British Medical Journal, 10/08/09
Relevance Score: 91%
Today in Renal/Urologic...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09

See Latest Articles